|
Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) Clinical research trials and Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL). Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) clinical trial. Subjects frequently obtain the most expert healthcare possible for their Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)  Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
For Condition: Leukemia, Lymphocytic, Chronic
Status: Recruiting
Sponsor(s): Ligand Pharmaceuticals ,
Synopsis: The purpose of this study is to evaluate the safety and effectiveness of ONTAK in previously treated patients with chronic lymphocytic leukemia (CLL)
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Patients with B-cell Chronic Lymphocytic Leukemia, Rai Stage 0-II with indication for treatment by NCI Working Group Criteria or Rai Stage III or IV. - Patients must have received at least one prior purine analogue-based chemotherapy regimen. - ECOG Performance Status of 0, 1, or 2. - Patients must not have had previous treatment with ONTAK. - Female patients cannot be pregnant and must use birth control during the course of the study and for three weeks after the study ends. - Patients must not receive therapy for CLL within 35 days prior to study.
Total Enrollment: 41
Location and Contact Information:
Overall Study Official:
GordonBray, Study Director, Ligand Pharmaceuticals
Peter MacCallum Cancer Institute *Recruiting*
East Melbourne, Victoria, 3002
Australia
Recruiting
Rush-Presbyterian St. Luke's Cancer Center *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting
UCSD School of Medicine *Recruiting*
La Jolla, California, 92093-0663
United States
Recruiting
University of Texas, M.D. Anderson Cancer Center *Recruiting*
Houston, Texas,
United States
Recruiting
Additional Information:
Study ID Numbers: L4389-34;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00055146
Other Leukemia, Lymphocytic, Chronic Studies:
1. Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
2. A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)
3. Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies
4. Clofarabine in Chronic Lymphocytic Leukemia
5. A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach
Related Studies:
Other Leukemia, Lymphocytic, Chronic Clinical Trials
Other Victoria Clinical Trials
Other East Melbourne Clinical Trials
Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
|
|
|
|
|
|
|
|
